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Summary
In this study the in vivo effect of natural micronised clinoptilolite and clinoptilolite
forte (clinoptilolite + 40 % extract of pulverised dried leaves of Urtica dioica L.) on the lipid
peroxidation and antioxidative capacity in mice was examined. This was done by measur-
ing the concentration of thiobarbituric acid reactive substances and total superoxide dis-
mutase content in the liver homogenate, and total antioxidant status in the plasma. The re-
sults obtained showed that the 12.5 % of tribomechanically micronised mineral zeolite forte
supplemented to food during 3 weeks significantly reduced lipid peroxidation process in
the liver. This was paralleled with a significant increase of total superoxide dismutase con-
tent, which was observed with both clinoptilolite and clinoptilolite forte. This study dem-
onstrates that clinoptilolite forte might be a novel class of lipid peroxidation inhibitors and
potent antioxidant.
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Introduction
Zeolites are natural or synthetic mesoporous or mi-
croporous silicate and alumosilicate crystals. They act as
catalysts, ion-exchangers, non-specific immunostimula-
tors or adjuvants in anticancer therapy (1). Zeolites pos-
sess the ability to bind oxygen, nitric oxide and 4-hydro-
xy-nonenal and may also have antioxidative or prooxi-
dative effect. Because of the need for novel compound
that will interact with free radicals, and which would
enable significant advances in the treatment of diseases,
these properties make it interesting for pharmaceutical
industry and biomedical application in recent years. Li-
pid peroxidation processes (LPO) generate highly toxic
molecules, which play substantial role in the organism
during aging and in several diseases/disorders (2). Free
radicals are eliminated from the body by their interac-
tion with antioxidants. Measurements of the capacity of
all the antioxidants present in plasma (TAS) establish the
links between antioxidant capacity and the risk of dis-
ease. They also provide a tool for monitoring antioxidant
therapy. At present, the assessment of the antioxidative
status of the body, as a clinical marker of oxidative
stress, is established using three approaches: (i) determi-
nation of TAS, which provides information about over-
all antioxidants and antioxidant enzyme concentrations
without the exact qualitative differentiation, (ii) determi-
nation of activity of selected antioxidant enzymes such
as total superoxide dismutase content (tSOD), (iii) moni-
toring the marker of oxidative stress, e.g. the concentra-
tion of thiobarbituric acid reactive substances (TBARS).
As shown in our previous results natural micronised
clinoptilolites (TMAZ) could have an important influ-
ence on the immunological parameters and inflamma-
tory processes (1), through the action on the superoxide
anions and nitric oxide. The purpose of our current in-
vestigation was to determine whether the TMAZ con-
taining plant extract (TMAZ forte) would have increased,
decreased or unchanged antioxidant properties. Recent-
ly, compounds with antioxidative properties have been
found within many natural substances isolated from
plant extracts (Rosmarinus officinalis, Polygonum hydropi-
per, etc.) (3).
It has recently been shown that the strongest anti-
cancer action has been observed by natural compounds
with multifunctional activity. Plant extracts from Urtica
dioica L. have pharmaceutical activities and clinical as-
sessment (4), they inhibit the synthesis of interleukin 1,
tumor necrosis factor and the proinflamatory transcrip-
tion factor NF- B (5). The elements important for free
radical reactions like Zn, Cu, Mg and Se were observed
in the leaf of Urtica dioica L. (6). Reduced serum levels of
Se may correlate with an increased incidence of cancer.
Thus, the characterisation of novel natural solids such as
natural micronised clinoptilolites (TMAZ) and TMAZ
forte (clinoptilolite + 40 % extract of Urtica dioica L.),
which would be more suitable for biomedical applica-
tion, are investigated. This article focuses on the oxida-
tive/antioxidative effect of TMAZ and TMAZ forte.
Materials and Methods
Four-month-old female mice of the CBA strain were
fed either with standard food or with standard food
supplemented with 12.5 % of TMAZ or TMAZ forte dur-
ing 3 weeks. TMAZ forte contained the extract of pulver-
ised dried leaves of Urtica dioica L. (Urticaceae) (40 % re-
ferred to the raw materials). TMAZ and TMAZ forte
were prepared freshly with water from pulverised stan-
dard food supplemented with pulverised TMAZ or
TMAZ forte, respectively. Each group of mice consisted
of 7 animals. Experiments were repeated 3 times.
The fine powder of natural clinoptilolites from the
eastern Balkan region was obtained by tribomechanical
micronisation. As it was described earlier (7), tribome-
chanically treated natural clinoptilolite contained mass
fraction of approximately 80 % clinoptilolite. The re-
maining 20 % consisted of silica, mordenite and mont-
morillonite zeolite. Chemical composition of clinoptilo-
lite was: SiO2 70.06 %, Al2O3 12.32 %, Fe2O3 1.48 %, CaO
3.42 %, MgO 0.96 %, TiO2 0.71 %, P2O5 0.05 %, MnO 0.02
%, Na2O 0.68 %, K2O 2.38 %, SO3 0.17 % and H2O 7.3 %.
Humidity at 105 °C was max. 6 %, pH=6.9–7.1, density
2.39 g/cm3, specific area 360–390 m2/g and NH4+ substi-
tution capacity 8 500 mg/kg. Maximum frequency of
clinoptilolite particle size appeared at 1 m. Particle size
distribution curves of clinoptilolites were taken by a
Mastersize XLB (Malvern) laser light-scattering particle
size analyser.
TBARS in the liver was estimated according to the
method of Okhawa et al. (8). TAS was determined by
commercially available kit (TAS Cat. No. NX 2332, RAN-
DOX Lab. Ardmore, UK). tSOD was determined by the
method of Cord and Fridovich (9). Protein concentration
was measured by the method of Lowry et al. (10).
The results are presented as mean values  SEM.
Statistical analysis of the data was done according to the
Student’s t-test for independent samples or the Mann
Whitney test. Values < 0.05 were considered significant.
Results
The effect of TMAZ or TMAZ forte on TAS,
tSOD and TBARS
As seen from Fig. 1A neither TMAZ ((0.450.04)
mmol/L) nor TMAZ forte ((0.520.04) mmol/L) changed
the TAS significantly as compared to TAS in the control
group ((0.480.04) mmol/L), fed with standard food.
The increase of TAS after the supplementation with
TMAZ forte, as compared to the control group, was not
significant. On the contrary, if standard food was sup-
plemented with 12.5 % of TMAZ (Fig. 1B), tSOD content
significantly increased (control: (1.410.18) g/mg pro-
tein; TMAZ: (1.840.17) g/mg protein; p<0.049). The
increase of tSOD content was much more pronounced
when TMAZ forte ((1.940.11) g/mg protein; p<0.011)
was added, as compared to control animals. The effect
of TMAZ or TMAZ forte on the liver TBARS concentra-
tion is shown in Fig. 1C. The concentration of TBARS
was unaffected if mice were fed with TMAZ ((1.130.03)
nmol/mg protein), as compared to the control mice
((1.140.02) nmol/mg protein), fed with standard food.
However, TMAZ forte ((1.010.03) nmol/mg protein)
significantly (p<0.034) reduced LPO processes, as seen
from TBARS concentration determined in the control.
Discussion
In our previous study (7) 12.5 % of TMAZ provided
beneficial effect on LPO process. In this study, we ob-
served that 12.5 % of TMAZ does not have significant
effect neither on LPO process nor on TAS capacity. This
was probably due to the form of feeding (per os). There-
fore, the mice were fed ad libitum with TMAZ or TMAZ
forte. Unlike TMAZ, TMAZ forte is able to inhibit LPO.
Although without the increase of TAS capacity, both
TMAZ and TMAZ forte have an impact on antioxidant
function through significant increase of tSOD content
(p<0.049 and p<0.011, respectively) in mice.
Because of the increased tSOD content, TMAZ and
TMAZ forte may have potentially important and benefi-
cial effect against cytotoxicity, chronic intoxication with
ethanol, mutagenicity and/or carcinogenicity, stress, pre-
vention of aging and the decline of immune system or
hazardous effects from environmental factors (11). TMAZ
and especially TMAZ forte contain Cu, Mg or Zn, which
are necessary for the production of tSOD. Through these
positive electrons TMAZ may neutralise free radicals.
TMAZ forte, because of the supplementation with Urtica
dioica L., in relation to TMAZ, contains additionally Se,
Zn, phytosterole, glucoquinone, phenolic compounds,
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vitamins C, A and E, which are essential for powerful
antioxidant activity (3). Our study demonstrates that the
effect of TMAZ forte, as an antioxidant and LPO inhibi-
tor, is stronger than that of TMAZ. These effects are
stronger probably due to tribomechanical micronisation
of the extract of Urtica dioica L. containing Se, flavonoids
and vitamin E. Vitamin E is relevant as LPO scavenger.
The extract of Urtica dioica L. decreased LPO level, as
observed by Kanter et al. (12) and Gulcin et al. (13). It
has recently been shown that extracts from Urtica dioica
L. have modulatory effects on phase II detoxification en-
zymes, including biotransformation enzymes, antioxi-
dant enzymes as well as lactate dehydrogenase and LPO
in mice (14). Many other natural products, the so-called
xenobiotics, induce phase II drug metabolising-detoxifi-
cation enzymes (15). Our results about the increased
tSOD activity along with the results of Ozen et al. (14)
suggest that TMAZ forte might be used as primary anti-
oxidant or inducer of phase II detoxification enzymes.
As such, TMAZ forte may prevent formation of new free
radical species. We could say that TMAZ forte might be
considered as novel class of LPO inhibitors.
Other possible mechanisms of synergistic action be-
tween TMAZ and Urtica dioica L. extract also exist. It has
recently been shown that anticancer activity of TMAZ is
due to its immunomodulatory effects (7). Recently strong
immunomodulatory effects have also been observed for
Urtica dioica L. extracts. Phenolic compounds such as
kaempherol or quercetin 3-O-ruthenoside present in Ur-
tica dioica L. extracts are responsible for immunostimu-
latory effects (16). Synergistic activity of TMAZ forte
components may indeed have a complex mechanism.
Future studies should be performed to identify how
much the micronised zeolites can potentiate the effects
of Urtica dioica L. extract.
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Fig. 1. a) total antioxidant status (TAS), b) total superoxide dis-
mutase content (tSOD) and c) thiobarbituric acid reactive sub-
stances concentration (TBARS) in control (C), mice fed with
standard food supplemented with 12.5 % of TMAZ (T) or 12.5
% of TMAZ forte (Tf) during 3 weeks. Each experimental group
consisted of 7 animals. Data are presented as mean value 
SEM of 3 repeated experiments
*p<0.049; ** p<0.011; p<0.034; compared to control
Antioksidativno djelovanje prirodnog mikroniziranog klinoptilolita i
smjese klinoptilolita s ekstraktom Urtica dioica L.
Sa`etak
U radu je istra`ivan in vivo u~inak mikroniziranog prirodnog klinoptilolita i klinopti-
lolita forte (klinoptilolit + 40 %-tni ekstrakt suhoga li{}a u prahu Urtica dioica L.) na per-
oksidaciju lipida i na antioksidativni kapacitet mi{eva. To je postignuto mjerenjem koncen-
tracije spojeva koji reagiraju s tiobarbiturnom kiselinom i odre|ivanjem udjela superoksid
dismutaze u homogenatu jetre te utvr|ivanjem ukupnog antioksidativnog statusa u plaz-
mi. Rezultati su pokazali da 12,5 %-tni tribomehani~ki mikronizirani mineral zeolit forte,
dodavan hrani tijekom tri tjedna, bitno smanjuje proces lipidne peroksidacije u jetri. Isto-
dobno je jako pove}an udjel superoksid dismutaze, {to je opa`eno pod utjecajem klino-
ptilolita i klinoptilolita forte. Istra`ivanja su pokazala da se klinoptilolit forte mo`e smatrati
novom vrstom inhibitora lipidne peroksidacije i sna`nim antioksidansom.
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